Found: 25
Select item for more details and to access through your institution.
In Silico Prophage Analysis of Halobacterium salinarum ATCC 33170.
- Published in:
- Applied Microbiology (2673-8007), 2024, v. 4, n. 2, p. 607, doi. 10.3390/applmicrobiol4020042
- By:
- Publication type:
- Article
Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 6, p. 1, doi. 10.1002/eji.202350620
- By:
- Publication type:
- Article
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1043, doi. 10.3390/vaccines11061043
- By:
- Publication type:
- Article
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV- 2 Omicron variant of concern.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1182556
- By:
- Publication type:
- Article
Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 140, doi. 10.3390/biomedicines11010140
- By:
- Publication type:
- Article
Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 11, p. 2291, doi. 10.3390/pharmaceutics14112291
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00540-7
- By:
- Publication type:
- Article
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13819-5
- By:
- Publication type:
- Article
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01363-7
- By:
- Publication type:
- Article
The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 205, doi. 10.3390/pharmaceutics13020205
- By:
- Publication type:
- Article
Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 257, doi. 10.3390/pharmaceutics13020257
- By:
- Publication type:
- Article
Adjuvanted Schistosoma mansoni -Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.605288
- By:
- Publication type:
- Article
Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.
- Published in:
- Biomedicines, 2019, v. 7, n. 4, p. 91, doi. 10.3390/biomedicines7040091
- By:
- Publication type:
- Article
Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 204, doi. 10.3390/vaccines7040204
- By:
- Publication type:
- Article
Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0208067
- By:
- Publication type:
- Article
An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma.
- Published in:
- Vaccines, 2017, v. 5, n. 4, p. 38, doi. 10.3390/vaccines5040038
- By:
- Publication type:
- Article
The Effect of Physicochemical Modification on the Function of Antibodies Induced by Anti-Nicotine Vaccine in Mice.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 11, doi. 10.3390/vaccines5020011
- By:
- Publication type:
- Article
Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.
- Published in:
- Immunity, Inflammation & Disease, 2016, v. 4, n. 2, p. 135, doi. 10.1002/iid3.98
- By:
- Publication type:
- Article
Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076557
- By:
- Publication type:
- Article
CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/636847
- By:
- Publication type:
- Article
Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge.
- Published in:
- Intervirology, 2006, v. 49, n. 3, p. 144, doi. 10.1159/000089375
- By:
- Publication type:
- Article
Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
- Published in:
- Immunology, 2004, v. 113, n. 2, p. 212, doi. 10.1111/j.1365-2567.2004.01962.x
- By:
- Publication type:
- Article
Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge(Kenneth L. Rosenthal is a Career Scientist from the Ontario HIV Treatment Network (OHTN).).
- Published in:
- Journal of Medical Virology, 2003, v. 71, n. 4, p. 561
- By:
- Publication type:
- Article
Optimization Strategies for DNA Vaccines.
- Published in:
- Intervirology, 2000, v. 43, n. 4-6, p. 218, doi. 10.1159/000053989
- By:
- Publication type:
- Article
The role of CpG in DNA vaccines.
- Published in:
- Springer Seminars in Immunopathology, 2000, v. 22, n. 1/2, p. 125, doi. 10.1007/s002810000014
- By:
- Publication type:
- Article